Qurin
Qurin is developing a test that detects cancer through urine instead of an invasive tissue biopsy, currently focusing on the early detection of bladder cancer.
”Qurin (Qurin Diagnostics) is a biotech R&D company based at Leiden Bio Science Park, with, among other things, a USD 2.3M subcontract within ARPA-H’s POSEIDON programme. Whereas cancer diagnostics typically rely on invasive tissue biopsies that provide only a local ‘snapshot’, Qurin is developing a platform for urine-based ‘liquid biopsy’ diagnostics (Qatra + Qumbra), currently focused on the early detection and monitoring of bladder cancer.